ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Patent Row: Delhi HC refuses to ban Natco Pharma's insecticide sale
The Delhi High Court has refused to stop Natco Pharma from selling an insecticide. FMC Corp had alleged patent infringement. The court noted Natco Pharma's strong defense and significant investments. The patent is also nearing expiry. FMC Corp's claims abo
Announcement as on 17 November 2025

Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China
Indian firms Hetero Labs Limited, Cipla Ltd, Annora Pharma Private Limited and Natco Pharma won the bids conducted by the Chinese health ministry for procurement of pharmaceuticals for its hospitals, according to the India-China Economic and Cultural Counc
Announcement as on 11 November 2025

Delhi HC allows Natco Pharma to launch risdiplam, rejects Roche plea
The Delhi High Court has permitted Natco Pharma to launch its affordable generic version of risdiplam, a crucial drug for spinal muscular atrophy. This decision overturns a previous stay, allowing Natco to offer the medication at a significantly lower pric
Announcement as on 09 October 2025

Natco Pharma's Kothur unit classified as 'voluntary action indicated' by US regulator
Natco Pharma Ltd announced that its Kothur unit in Hyderabad received an Establishment Inspection Report (EIR) from the US FDA, classifying the facility as 'Voluntary Action Indicated' (VAI). The US FDA had previously conducted an inspection of the company
Announcement as on 18 September 2025

Natco Pharma sues Novo Nordisk in generic drug push
The lawyers representing Natco Pharma informed the court that over the past few months it had approached Novo Nordisk to communicate on its non-infringing patents but received no response, said people familiar with the matter. "A clear communication from t
Announcement as on 21 August 2025

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 927.78
  • 12Day Average: 940.53
  • 20Day Average: 950.07
  • 50Day Average: 955.78
  • 100Day Average: 1007.61
  • 150Day Average: 964.48
  • 200Day Average: 936.42

524816 Indicators & signals

Indicator MACD (12,26,9)

936.75, 942.72, -4.43
Indicator MACD is in negative zone

Indicator ADX (14)

4.61, 19.14, 17.45
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Thu Jul 2026 930.70 926.10 to 945.00 -0.52% 0.33 times
29 Wed Jul 2026 935.60 925.70 to 941.10 1.18% 0.26 times
28 Tue Jul 2026 924.65 920.40 to 934.85 -0.27% 0.73 times
27 Mon Jul 2026 927.15 921.45 to 938.35 0.69% 0.3 times
24 Fri Jul 2026 920.80 911.70 to 926.90 0.21% 0.94 times
23 Thu Jul 2026 918.85 916.45 to 938.00 -1.71% 1.15 times
22 Wed Jul 2026 934.80 927.40 to 955.10 -2.82% 1.57 times
21 Tue Jul 2026 961.95 949.40 to 965.05 1.2% 0.42 times
20 Mon Jul 2026 950.55 948.50 to 986.00 0.51% 2.02 times
17 Fri Jul 2026 945.75 941.65 to 974.75 -2.07% 2.05 times
16 Thu Jul 2026 965.75 960.00 to 982.50 -0.41% 0.57 times
15 Wed Jul 2026 969.75 964.70 to 989.75 -0.22% 0.46 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top